Bone Abstracts

Objective: To evaluate prevalent risk factors, medication use and comorbidities with bone mass findings at the total hip, femoral neck and lumbar spine.Design: Historical cross-sectional study.Methods: A total of 6285 women and 565 men consecutively referred to an osteoporosis specialist clinic from 2000 to 2012 were included. Information of potential risk factors was obtained from a clinical database. Additional information on med...

DMAb increases BMD and reduces bone resorption and risk of vertebral, nonvertebral and hip fractures in women with PMO. Transiliac crest bone biopsies in 47 subjects treated with DMAb for 1–3 years showed reduced bone turnover vs 45 Pbo-treated subjects, which reversed on treatment cessation. Since bone turnover reduction is sustained and fracture incidence low over 6 years’ DMAb treatment, we evaluated DMAb’s effects on tissue-level remodelling in the FREEDOM E...